By Blake Brittain
Feb 21 - Medical diagnostics company Guardant Health GH.O has sued rival Natera NTRA.O in California federal court for allegedly stealing trade secrets related to cancer-detection blood tests.
Guardant said in a lawsuit filed Thursday that scientists poached by Natera transferred thousands of confidential files to the company to develop competing tests.
A Natera spokesperson said on Friday that the complaint was "riddled with baseless allegations" and that the company would defend itself against the claims.
Attorneys and spokespeople for Guardant did not immediately respond to requests for comment on Friday.
The case is one of several contentious legal disputes among competitors in the genomics industry, which involves the science of the human genome. The global genomics market was worth nearly $34 billion in 2023 and could grow to $157 billion by 2033, according to a report from biopharmaceutical news outlet BioSpace.
Guardant won a $292.5 million false advertising verdict against Natera in November over allegations that it made misleading claims comparing the companies' colorectal cancer blood tests.
Guardant's new lawsuit said its Shield was the first FDA-approved early cancer blood test. According to the complaint, Natera began targeting Guardant employees "aggressively" to "jumpstart its lagging position in the early cancer test industry."
Guardant said that two of its scientists, Alan Selewa and Catalin Barbacioru, left the company for Natera earlier this year. The complaint alleged both scientists transferred secret files about the company's blood tests to external hard drives before leaving to share them with Natera.
Selewa and Barbacioru could not immediately be reached for comment on the allegations.
Guardant asked the court for an order blocking the scientists from sharing its secrets and an unspecified amount of monetary damages.
The case is Guardant Health Inc v. Natera Inc, U.S. District Court for the Northern District of California, No. 3:25-cv-01837.
For Guardant: Jennifer Keller and Chase Scolnick of Keller Anderle Scolnick
For Natera and the scientists: attorney information not yet available
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。